Ask AI
First-line Zongertinib
Beamion LUNG-1: Phase I Study of Zongertinib as First-line Treatment for Advanced HER2-Mutant NSCLC

Released: October 27, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 27, 2025